Milestone announces acceptance of MAA by EMA for etripamil nasal spray
Milestone Pharmaceuticals (MIST) announced the acceptance of a Marketing Authorization Application, MAA, by the European Medicines Agency, EMA,…
Aptar’s Bidose Nasal System Delivers CARDAMYST™ (etripamil), the First and Only Self-Administered FDA-Approved Nasal Spray for Paroxysmal Supraventricular Tachycardia (PSVT)
Milestone Pharmaceuticals received U.S. Food and Drug Administration approval of CARDAMYST for the conversion of acute symptomatic episodes…
Milestone Pharma gets FDA approval for first PSVT nasal spray
Milestone (Nasdaq: MIST) announced FDA approval of CARDAMYST (etripamil) nasal spray for conversion…
Walgreens recalls nasal spray over possible contamination
(CNN) – Walgreens is recalling more than 41,000 bottles of nasal spray because they may be contaminated with…
Walgreens recalls nasal spray over possible contamination
(CNN) – Walgreens is recalling more than 41,000 bottles of nasal spray because they may be contaminated with…